Navigation Links
Quality of medicines and food ingredients the focus at USP 2009 Annual Scientific Meeting
Date:9/9/2009

tion of suspected counterfeit drugs.

Highlights of this year's program include sessions on:

  • Canadian Food and Drug Regulation (Wednesday, September 23, 2009)
  • Biomeasurement, featuring scientists from Brazil, Canada, China, the United Kingdom and the United States (Thursday, September 24, 2009)
  • Nanotherapeutics and Measurement (Friday, September 25, 2009)

Registration can be completed online at: http://www.usp.org/goto/asm. The registration rate is $1,350 per person. On-site registration will be available. A special rate of $650 is offered to associations, academia and government. Please email conferences@usp.org for the group rate. The registration fee covers the program, meeting materials, breakfast and lunch daily, and all meeting social activities.


'/>"/>

Contact: Sandra Kim
sek@usp.org
301-816-8241
US Pharmacopeia
Source:Eurekalert

Page: 1 2

Related biology news :

1. Water quality improves after lawn fertilizer ban, study shows
2. Improved air quality during Beijing Olympics could inform pollution-curbing policies
3. Dietary supplements manufacturers gain new tool to help ensure quality products
4. Quality and purity of popular stevia sweetener strengthened by new reference standards
5. Prefilled WFI Syringe Provides a High-Quality Solution for Drug Reconstitution
6. Enhanced quality of LIFE through Nordic food
7. Houseplants increase quality of life for retirement community residents
8. Healthy food availability could depend on where you live -- so does the quality of your diet
9. New research shows high-quality protein in eggs contributes to power, strength and energy
10. New standard for popular stevia-based sweetener to assure products quality
11. Biological sand filters, a practical approach to combat poverty and inequality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/19/2015)... March 19, 2015  NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market, announces its biometric payment ... clip that aired this week on Washington DC,s ... In a segment "The Next Great Thing", host ... way to pay, and ,a really big breakthrough in mobile ...
(Date:3/17/2015)... 17, 2015 Emotient, the leader in ... announced general availability of Emotient Analytics , ... analysis of facial expressions. The system analyzes videos ... products and services. It delivers audience response metrics ... - as derived from facial evidence of emotional ...
(Date:3/12/2015)... 12, 2015 IriTech, a leading iris based ... the Texas Instruments Design Network, announced today that the ... its IriShield USB MK2120U device during a launching event ... distribution. The iris scanner is manufactured ... in India through its Indian ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3
... (NAS) and Institute of Medicine (IOM) today released SCIENCE, ... public a comprehensive and up-to-date picture of the current ... science classroom. Recent advances in science and medicine, ... the past 150 years, have reinforced evolution,s role as ...
... the latest American Chemical Society (ACS) News Service Weekly PressPac ... Engineering News.,Please credit the individual journal or the American Chemical ... IS FOR IMMEDIATE USE EXCEPT ARTICLE #5, which is embargoed ... ARTICLE #1 FOR IMMEDIATE RELEASE ...
... researchers have uncovered a critical difference between flu viruses that ... monitor the evolution of avian flu strains and aid in ... The researchers found that a virus,s ability to infect humans ... of receptor on the surface of human respiratory cells. ...
Cached Biology News:Scientific evidence supporting evolution continues to grow 2Scientific evidence supporting evolution continues to grow 3American Chemical Society's weekly PressPac -- Jan. 2, 2008 2American Chemical Society's weekly PressPac -- Jan. 2, 2008 3American Chemical Society's weekly PressPac -- Jan. 2, 2008 4American Chemical Society's weekly PressPac -- Jan. 2, 2008 5American Chemical Society's weekly PressPac -- Jan. 2, 2008 6American Chemical Society's weekly PressPac -- Jan. 2, 2008 7American Chemical Society's weekly PressPac -- Jan. 2, 2008 8American Chemical Society's weekly PressPac -- Jan. 2, 2008 9MIT finds key to avian flu in humans 2MIT finds key to avian flu in humans 3
(Date:3/30/2015)... BELLINGHAM, Washington, USA (PRWEB) March 29, 2015 ... Europe and the United States and plenary talks by ... for SPIE Optics + Optoelectronics next month ... 700 technical presentations in 17 conferences alongside a two-day ... optics and photonics , the event will run 13-16 ...
(Date:3/30/2015)... Wis. , March 30, 2015  FUJIFILM Holdings ... and Cellular Dynamics International, Inc. (CEO: Robert J. ... developer and manufacturer of fully functioning human cells in ... two companies have entered into a definitive agreement whereby ... to be followed by a second step merger. Fujifilm ...
(Date:3/29/2015)... As a symbol of its commitment to ... manufacturing clients, Whitehouse Laboratories is excited to announce that ... Team for the 2015 race season. Success on the ... strong sense of precision and attention to detail. These ... the quality control testing laboratory. Sponsorship of the race ...
(Date:3/27/2015)...  Neogen Corporation (NASDAQ: NEOG ) announced today ... plan in accordance with Securities and Exchange Commission rule ... Neogen Corporation, is a minority owner of this entity ... Herbert does not have control of this entity, ... only for a portion of the shares owned by ...
Breaking Biology Technology:Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 2Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 3Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 4Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 5Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 6Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 7Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 8Whitehouse Laboratories Reaffirms Commitment to Speedy Results – Renews Sponsorship of Berkenstock Racing Team 2Neogen CEO adopts 10b5-1 Trading Plan 2
... and LUND, Sweden, February 23 , ... Partial Factor VIII Inhibition in,Patients Undergoing Knee Replacement Surgery ... THR) and co-development partner,BioInvent International (OMXS: BINV) announce today ... II trial with their long-acting anticoagulant,TB-402 for the prophylaxis ...
... SANTA MONICA, Calif., Feb. 20 Cord Blood ... cord blood stem cell preservation company ( http://www.cordblood-america.com ... of stem cells to families nationwide and internationally, ... in an interview with analyst Francis Gaskins, provided ...
... Natural and Organic,Cosmetic* products are now identifiable at ... 100 products have already been certified as of ... NaTrue-Label provides orientation for consumers and manufacturers,alike by ... Organic,Cosmetics. It is international, not for profit, open ...
Cached Biology Technology:ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis 2ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis 3ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis 4ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis 5In Analyst Interview, Cord Blood America Provides Details of Special Shareholder Meeting 2NaTrue-Label: The First 100 Products are Certified 2